Brief: Diagonal Bio Approved For Delisting From Nasdaq First NGM
04/03/2025 15:48
March 4 (Reuters) - Diagonal Bio AB DIABIO.ST: DIAGONAL BIO HAS BEEN APPROVED FOR DELISTING FROM NASDAQ FIRST NORTH GROWTH MARKET LAST DAY OF TRADING ON FIRST NORTH IS 18 MARCH 2025 Source text: ID:nWkrBtZgT Further company coverage: DIABIO.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Diagonal Bio AB
See all newsBrief: Diagonal Bio Approved For Delisting From Nasdaq First NGM
Brief: Diagonal Bio Gets Conditional Approval For Listing On NGM Nordic SME
Brief: Diagonal Bio Applies For Change Of Marketplace To NGM Nordic SME
Brief: Diagonal Bio Resolves On Directed Issue Of Units To All External Underwriters
Brief: Diagonal Bio Says Positive Pilot Test Results, Gets Order From Stallzet